Paramesh Anil S, Killackey Mary T, Zhang Rubin, Alper Brent, Slakey Douglas P, Florman Sander S
Tulane Abdominal Transplant Institute, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.
South Med J. 2007 Dec;100(12):1208-13. doi: 10.1097/SMJ.0b013e31815a9a98.
The use of living donor kidneys has dramatically increased the number and success of kidney transplants across the world. But questions remain regarding the subjection of a healthy individual to surgery for the benefit of another. Donors do have medical and financial risks. The stigma of organ brokering remains today, with evidence of commercial transplantation in other countries. Here in the US, we are exposed to advertising for donors using the media. In the hope of increasing living donations, we run the risk of stretching altruism too far. In this manuscript, we highlight and discuss some of the current controversies surrounding living donor kidney transplantation across the world.
活体供肾的使用显著增加了全球肾移植的数量并提高了成功率。但对于让一个健康个体为了他人利益而接受手术,仍存在诸多问题。供体确实存在医疗和经济风险。如今,器官买卖的污名依然存在,其他国家有商业移植的证据。在美国,我们会接触到媒体上关于寻求供体的广告。为了增加活体捐赠,我们有可能将利他主义延伸得太远。在本手稿中,我们重点介绍并讨论了当前全球围绕活体供肾移植的一些争议。